Title |
PV-1 is recognized by the PAL-E antibody and forms complexes with NRP-1
|
---|---|
Published in |
Blood, May 2012
|
DOI | 10.1182/blood-2012-01-406876 |
Pubmed ID | |
Authors |
Johannes Keuschnigg, Denis Tvorogov, Kati Elima, Marko Salmi, Kari Alitalo, Tiina Salminen, Sirpa Jalkanen |
Abstract |
Pathologische anatomie leiden endothelium (PAL-E) antibody has been used for more than 20 years as a prototype marker for vascular endothelium. The elusive target of this antibody has been claimed to be plasmalemma vesicle-associated protein-1 (PV-1) and neuropilin-1 (NRP-1). Using immunofluorescence, we show that PAL-E, anti-PV-1, anti-NRP-1, and anti-CD31 antibodies show largely identical staining patterns in the vasculature of different tissues. However, PV-1-transfected cells only bind PAL-E and anti-PV-1 antibodies, whereas NRP-1 transfectants stain with anti-NRP-1 antibodies in flow cytometry. Using lysates from tissues and transfected cells, we further confirm that the molecule recognized by PAL-E and anti-PV-1 antibodies is not NRP-1 but PV-1. Nevertheless, coimmunoprecipitation studies unambiguously demonstrate that NRP-1 can form complexes with PV-1. This connects, for the first time, 2 molecules involved in leukocyte trafficking and angiogenesis, thereby opening interesting possibilities for future research in this field. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 3% |
Unknown | 31 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 31% |
Student > Ph. D. Student | 8 | 25% |
Student > Master | 4 | 13% |
Lecturer > Senior Lecturer | 2 | 6% |
Professor > Associate Professor | 2 | 6% |
Other | 5 | 16% |
Unknown | 1 | 3% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 34% |
Biochemistry, Genetics and Molecular Biology | 9 | 28% |
Immunology and Microbiology | 6 | 19% |
Medicine and Dentistry | 3 | 9% |
Neuroscience | 2 | 6% |
Other | 0 | 0% |
Unknown | 1 | 3% |